Literature DB >> 9557157

Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection.

J F Tsai1, H S Margolis, J E Jeng, M S Ho, W Y Chang, M Y Hsieh, Z Y Lin, J H Tsai.   

Abstract

For assessing the role of circulating immune complexes (CIC) in chronic hepatitis B virus (HBV) infection, CICs containing IgM, IgG, and HBsAg were determined by C1q and conglutinin (K) assays in 216 patients with chronic HBV infection and 54 healthy controls. The concentration of each type of CIC in patients is higher than in controls (P = 0.0001). CIC is a common feature of chronic HBV infection with 95.8% of cases having at least one abnormal test result. At least one type of HBsAg-CIC is positive in 54.2% of patients. HBsAg-CIC positivity is associated with HBeAg positivity (P = 0.0001), higher aminotransferase levels (P < 0.002), and younger age (P = 0.001). IgG-CIC or IgM-HBsAg-CIC correlates with higher aminotransferase activity (P = 0.001). In conclusion, HBsAg-CIC correlates with HBV replication. IgG-CIC and/or IgM-HBsAg-CIC correlate with disease activity. Immune-mediated injury may play a role in the pathogenesis of chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557157     DOI: 10.1006/clin.1997.4477

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Catherine A Scougall; Ieva Kotlarski; Richard J Colonno; Allison R Jilbert
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  The injured liver induces hyperimmunoglobulinemia by failing to dispose of antigens and endotoxins in the portal system.

Authors:  Wen Ting Liu; Ying Ying Jing; Zhi Peng Han; Xiao Ning Li; Yan Liu; Fo Bao Lai; Rong Li; Qiu-Dong Zhao; Meng-Chao Wu; Li-Xin Wei
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

3.  Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.

Authors:  Michel Bazinet; Mark Anderson; Victor Pântea; Gheorghe Placinta; Iurie Moscalu; Valentin Cebotarescu; Lilia Cojuhari; Pavlina Jimbei; Liviu Iarovoi; Valentina Smesnoi; Tatina Musteata; Alina Jucov; Ulf Dittmer; Jeff Gersch; Vera Holzmayer; Mary Kuhns; Gavin Cloherty; Andrew Vaillant
Journal:  Hepatol Commun       Date:  2021-07-10

4.  Analysis of S gene characteristic sequences and changes in properties of protein expression in HBV ASCs with low-level HBsAg.

Authors:  Yu Yu; Yingqiang Zhang; Yuzhu Dai; Qingyang Sun; Chun Jiang; Xujian Xu; Chuanzhong Mei; Jun Cheng
Journal:  Front Med (Lausanne)       Date:  2022-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.